DK2642980T3 - Pædiatrisk formulering - Google Patents

Pædiatrisk formulering Download PDF

Info

Publication number
DK2642980T3
DK2642980T3 DK11794307.6T DK11794307T DK2642980T3 DK 2642980 T3 DK2642980 T3 DK 2642980T3 DK 11794307 T DK11794307 T DK 11794307T DK 2642980 T3 DK2642980 T3 DK 2642980T3
Authority
DK
Denmark
Prior art keywords
pediatric formulation
pediatric
formulation
Prior art date
Application number
DK11794307.6T
Other languages
English (en)
Inventor
Mingda Bi
Fernando Alvarez-Nunez
Francisco Javier Alvarez
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK2642980T3 publication Critical patent/DK2642980T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK11794307.6T 2010-11-23 2011-11-23 Pædiatrisk formulering DK2642980T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41666210P 2010-11-23 2010-11-23
PCT/US2011/062085 WO2012071535A2 (en) 2010-11-23 2011-11-23 Pediatric formulation

Publications (1)

Publication Number Publication Date
DK2642980T3 true DK2642980T3 (da) 2020-06-22

Family

ID=45316075

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11794307.6T DK2642980T3 (da) 2010-11-23 2011-11-23 Pædiatrisk formulering

Country Status (15)

Country Link
US (3) US20140147497A1 (da)
EP (1) EP2642980B8 (da)
CA (1) CA2818565A1 (da)
CY (1) CY1123700T1 (da)
DK (1) DK2642980T3 (da)
ES (1) ES2793724T3 (da)
HR (1) HRP20200691T1 (da)
HU (1) HUE049344T2 (da)
LT (1) LT2642980T (da)
PL (1) PL2642980T3 (da)
PT (1) PT2642980T (da)
RS (1) RS60203B1 (da)
SI (1) SI2642980T1 (da)
SM (1) SMT202000314T1 (da)
WO (1) WO2012071535A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2730279T3 (pl) * 2012-11-09 2015-12-31 K H S Pharma Holding Gmbh Preparaty cynakalcetu o natychmiastowym uwalnianiu
WO2014207691A1 (en) 2013-06-26 2014-12-31 Jubilant Life Sciences Limited Disintegrant free composition of cinacalcet
WO2015136329A1 (en) * 2014-03-14 2015-09-17 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical composition of cinacalcet
KR101680464B1 (ko) 2015-04-17 2016-11-28 가톨릭대학교 산학협력단 시나칼셋을 유효성분으로 함유하는 당뇨병성 미세혈관 합병증의 예방 및 치료용 약학적 조성물
EP3241549A1 (en) 2016-05-02 2017-11-08 Sun Pharmaceutical Industries Limited Sprinkle composition of cinacalcet

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965252A (en) * 1988-06-28 1990-10-23 Hauser-Kuhrts, Inc. Cholesterol-lowering combination compositions of guar gum and niacin
AR045637A1 (es) * 2003-09-12 2005-11-02 Amgen Inc Formulacion de disolucion rapida de un compuesto activo frente a los receptores de calcio
WO2008027522A2 (en) * 2006-09-01 2008-03-06 Teva Pharmaceutical Industries Ltd. Solid composites of a calicum receptor-active compound
WO2008064202A2 (en) * 2006-11-20 2008-05-29 Dr. Reddy's Labortories, Ltd. Modified-release formulations of calcium receptor-active compounds

Also Published As

Publication number Publication date
SMT202000314T1 (it) 2020-07-08
WO2012071535A2 (en) 2012-05-31
LT2642980T (lt) 2020-05-25
HUE049344T2 (hu) 2020-09-28
US20140147497A1 (en) 2014-05-29
US20180098940A1 (en) 2018-04-12
PL2642980T3 (pl) 2020-09-21
ES2793724T3 (es) 2020-11-16
EP2642980B8 (en) 2020-06-03
WO2012071535A3 (en) 2012-08-16
PT2642980T (pt) 2020-06-24
EP2642980A2 (en) 2013-10-02
US20190216737A1 (en) 2019-07-18
RS60203B1 (sr) 2020-06-30
CY1123700T1 (el) 2022-03-24
CA2818565A1 (en) 2012-05-31
HRP20200691T1 (hr) 2020-07-24
SI2642980T1 (sl) 2020-07-31
EP2642980B1 (en) 2020-04-08

Similar Documents

Publication Publication Date Title
FIC20250038I1 (fi) Donanemabi
NL300986I2 (nl) lanadelumab
DK2525798T3 (da) Anæstetisk formulering
NO2017034I1 (no) Idarucizumab
IL245328A0 (en) Pharmaceutical composition
BR112012033478A2 (pt) dispositivo médico
BR112013013263A2 (pt) conjunto de conexão
PL2611310T3 (pl) Formulacja antybakteryjna
PT2552242E (pt) Resumo
BRPI1009465A2 (pt) Formulação
EP2552212A4 (en) IMPROVED FORMULATION
GT201200303A (es) Formulaciones farmacéuticas
EP2623153A4 (en) INTERCONNECTS
EP2531023A4 (en) IMPROVED FORMULATION
EP2584243A4 (en) INTERCONNECTS
BR112014000015A2 (pt) formulação
DK2635269T3 (da) Kombinationspræparat
DK2444068T3 (da) Brimonidingelpræparat
BR112012022411A2 (pt) articulador
DE112011103919A5 (de) Endoskop
DK2568948T3 (da) Tilslutningsindretning
EP2770828A4 (en) FORMULATION
DE102010051388A8 (de) Verbindungsvorrichtung
EP2633219A4 (en) INTERCONNECTS
EP2556786A4 (en) Endoscope